11
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Carvastatin suppresses intimal thickening of rabbit carotid artery after balloon catheter injury probably through the inhibition of vascular smooth muscle cell proliferation and migration

, , , , &
Pages 159-166 | Published online: 08 Jul 2009

REFERENCES

  • Brown MS. Goldstein JL. . Receptor-mediated control of cholesterol metabolism. Science 1976; 191: 150–4.
  • Corsini A, Raiteri M, Soma MR, Fumaglli R, Paoletti R. Simvastatin but not pravastatin inhibits the proliferation of rat aorta myocytes. Pharmacol Res 1991; 23: 173–80.
  • Hidaka Y, Eda T, Yonemoto M, Kamei T. Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733). Athero-sclerosis 1992; 95: 87–94.
  • Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–9.
  • Sahni R, Maniet AR, Voci G, Banka VS. Prevention of restenosis by lovastatin after suc-cessful coronary angioplasty. Am Heart J 1990; 121: 1600–8.
  • Brown MS, Faust JR, Goldstein JL, Kaneko I, Endo A. Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibro-blasts induced with compactin (ML-236B), a competitive inhibitor of the reductase. J Biol Chem 1978; 253: 1121–8.
  • Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345–3.
  • Bilheimer DW, Eisenberg S, Levy RI. The metabolism of very low density lipoproteins I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta 1979; 260: 212–21.
  • Glodstein JL, Basu SK, Brown MS. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol 1983; 98: 241–61.
  • Manderson JA, Mosse PRL, Safstrom JA, Young SB, Campbell GR. Balloon catheter injury to rabbit carotid artery. I. Changes in smooth muscle phenotype. Arteriosclerosis 1989; 9: 289–98.
  • Shinomiya M, Shirai K, Saito Y, Yoshida S. Inhibition of intimal thickening of the carotid artery of rabbits and of outgrowth of explants of aorta by probucol. Atherosclerosis 1992; 97: 143–8.
  • Fischer-Dzoga K, Jones RM, Vesselinovitch D, Wissler RW. Ultrastructural and immunohisto-chemical studies of primary cultures of aortic medial cells. Exp Mol Pathol 1976; 18: 162— 76.
  • Koyama N, Morisaki N, Saito Y, Yoshida S. Regulatory effects of platelet-derived growth factor—AA homodimer on migration of vascular smooth muscle cells. J Biol Chem 1992; 267: 22806 — 12.
  • Endo A. The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res 1992; 33: 1569–82.
  • Koga T, Shimada Y, Kuroda M, Tsujita Y, Hasegawa K, Yamazaki M. Tissue-selective inhi-bition of cholesterol synthesis in vivo by pra-vastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Biochim Biophys Acta 1990; 1045: 115–20.
  • Soma MR, Donetti E, Parolini C, Mazzini G, Ferrari C, Fumaglli R, Paoletti R. HMG-CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rab-bits. Arterioscler Thromb 1993; 13: 571–8.
  • Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990; 343: 425–30.
  • Takai Y, Kaibuchi K, Kikuchi A, Kawata M. Small GTP-binding proteins. Int Rev Cytol 1992; 133: 187–230.
  • Casey PJ, Solski PA, Der CJ, Buss JE. p21 ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci USA 1989; 86: 8323–7.
  • Miura Y, Kikuchi A, Musha T, Kuroda S, Yaku H, Sasaki T, Takai Y. Regulation of morphology by rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI) in swiss 3T3 cells. J Biol Chem 1993; 268: 510–15.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.